Article Details

Novo Nordisk, Ventus Enter Licensing Deal With Potential Value Of $700M

Retrieved on: 2022-09-30 20:32:35

Tags for this article:

Click the tags to see associated articles and topics

Novo Nordisk, Ventus Enter Licensing Deal With Potential Value Of $700M. View article details on hiswai:

Excerpt

"The collaboration validates the company's structural biology ... development of “highly differentiated molecules with novel chemical structures," ...

Article found on: www.contractpharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up